Market Value3,012,659,187
Total Holdings83
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ABT / Abbott Laboratories
MRK / Merck & Co., Inc.
JAZZ / Jazz Pharmaceuticals plc
ISEE / IVERIC bio Inc
FUSN / Fusion Pharmaceuticals Inc.
ANTX / AN2 Therapeutics, Inc.
ICLR / ICON Public Limited Company
KPTI / Karyopharm Therapeutics Inc.
SGRY / Surgery Partners, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
CMPX / Compass Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
DNAD / Social Capital Suvretta Holdings Corp IV - Class A
DNAB / Social Capital Suvretta Holdings Corp II
VRTX / Vertex Pharmaceuticals Incorporated
MSAC / Medicus Sciences Acquisition Corp - Class A
KYG5960S1241 / Medicus Sciences Acquisition Corp.
FATE / Fate Therapeutics, Inc.
DGX / Quest Diagnostics Incorporated
NSTG / NanoString Technologies, Inc.
RXDX / Prometheus Biosciences Inc
ARWR / Arrowhead Pharmaceuticals, Inc.
REUN / Reunion Neuroscience Inc
KNTE / Kinnate Biopharma Inc.
HYPR / Hyperfine, Inc.
ZTS / Zoetis Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
PANA / Panacea Acquisition Corp II - Class A
HSAQ / Health Sciences Acquisitions Corp 2
GRPH / Graphite Bio, Inc.
BLU / Bellus Health Inc
BCAB / BioAtla, Inc.
IPSC / Century Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
PACB / Pacific Biosciences of California, Inc.
CYTK / Cytokinetics, Incorporated
BIO / Bio-Rad Laboratories, Inc.
VIR / Vir Biotechnology, Inc.
PLRX / Pliant Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
LLY / Eli Lilly and Company
VERV / Verve Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
ETNB / 89bio, Inc.
MLYS / Mineralys Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
BIIB / Biogen Inc.
PRTA / Prothena Corporation plc
RNA / Avidity Biosciences, Inc.
COR / Cencora, Inc.
CYTT / Cyteir Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
AXSM / Axsome Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
NTRA / Natera, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
CVAC / CureVac N.V.
MDGL / Madrigal Pharmaceuticals, Inc.
UTHR / United Therapeutics Corporation
EPIX / ESSA Pharma Inc.
PNT / POINT Biopharma Global Inc.
RCKT / Rocket Pharmaceuticals, Inc.
PRAX / Praxis Precision Medicines, Inc.
GERN / Geron Corporation
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
SGMO / Sangamo Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
COLL / Collegium Pharmaceutical, Inc.
IMVT / Immunovant, Inc.
NBIX / Neurocrine Biosciences, Inc.
/ CareMax Inc
BDX / Becton, Dickinson and Company
UHS / Universal Health Services, Inc.
ACIU / AC Immune SA
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
SCYX / SCYNEXIS, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
BSX / Boston Scientific Corporation
PHAT / Phathom Pharmaceuticals, Inc.
ITCI / Intra-Cellular Therapies, Inc.
TWST / Twist Bioscience Corporation
CRBU / Caribou Biosciences, Inc.
ACHC / Acadia Healthcare Company, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
NTLA / Intellia Therapeutics, Inc.
ARVN / Arvinas, Inc.
DXCM / DexCom, Inc.
IDYA / IDEAYA Biosciences, Inc.
AKRO / Akero Therapeutics, Inc.
THC / Tenet Healthcare Corporation
RARE / Ultragenyx Pharmaceutical Inc.
AVTR / Avantor, Inc.
BHVN / Biohaven Ltd.
KZR / Kezar Life Sciences, Inc.
BMRN / BioMarin Pharmaceutical Inc.
VTYX / Ventyx Biosciences, Inc.
ALT / Altimmune, Inc.